Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-11-18

Clinical Trial Update: Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating stereotactic hypofractionated radiosurgery for early-stage prostate cancer. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: San Diego Radiosurgery | Conditions: Prostate Cancer | Phase 1 | Status: UNKNOWN